Beam Therapeutics Presents Additional Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at 2025 Alpha-1 Foundation 7th Global Research Conference and 10th Patient Congress

2 months ago 10
Read Entire Article
  1. Homepage
  2. Finance
  3. Beam Therapeutics Presents Additional Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at 2025 Alpha-1 Foundation 7th Global Research Conference and 10th Patient Congress

Related

Universal Health Services' SWOT analysis: stock outlook amid policy risks, growth potential

Universal Health Services' SWOT analysis: stock outlook amid...

8 minutes ago 0
Global Net Lease's SWOT analysis: stock transformation amid de-leveraging push

Global Net Lease's SWOT analysis: stock transformation amid ...

8 minutes ago 0
Cloudflare's SWOT analysis: stock poised for growth amid AI boom and security demand

Cloudflare's SWOT analysis: stock poised for growth amid AI ...

8 minutes ago 0

Trending

1. bailey zimmerman
2. rangers
3. tbs
4. fc dallas vs sporting kc
5. citadel
6. ricky simon
7. west point
8. panthers vs oilers
9. real madrid
10. texas rangers

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

4 months ago 267
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

3 months ago 149
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

5 months ago 147
TOUS les JOURS Opens in Henderson!

TOUS les JOURS Opens in Henderson!

4 months ago 116
Sole mates: Find the perfect shoes for your fitness journey

Sole mates: Find the perfect shoes for your fitness journey

4 months ago 111
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved